We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$585M
AUM Growth
+$56.2M
(+11%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$33.9M |
| 2 |
Verizon
VZ
|
+$6.56M |
| 3 |
Lowe's Companies
LOW
|
+$6.21M |
| 4 |
Procter & Gamble
PG
|
+$6.15M |
| 5 |
Danaher
DHR
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$12.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 3 |
Apple
AAPL
|
+$11.1M |
| 4 |
UnitedHealth
UNH
|
+$9.36M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.76% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Healthcare | 14.64% |
| 4 | Consumer Staples | 12.4% |
| 5 | Miscellaneous | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$827B
| $35.5M | 6.06% |
+110,200
| New | +$33.9M |
|
2
Target
TGT
$75.4B
| $11.4M | 1.94% |
88,724
+200
| +0.2% | +$23.5K |
|
3
Walmart Inc
WMT
$817B
| $7.95M | 1.36% |
200,628
+51,600
| +35% | +$2.05M |
|
4
Coca-Cola
KO
$383B
| $6.97M | 1.19% |
125,900
+46,800
| +59% | +$2.52M |
|
5
Starbucks
SBUX
$122B
| $6.69M | 1.14% |
76,100
+29,100
| +62% | +$2.48M |
|
|
6
Verizon
VZ
$205B
| $6.68M | 1.14% |
+108,800
| New | +$6.56M |
|
|
7
Lowe's Companies
LOW
$116B
| $6.5M | 1.11% |
+54,300
| New | +$6.21M |
|
8
Roku
ROKU
$23.2B
| $6.35M | 1.09% |
47,400
+8,900
| +23% | +$1.22M |
|
|
9
Procter & Gamble
PG
$333B
| $6.28M | 1.07% |
+50,300
| New | +$6.15M |
|
|
10
Danaher
DHR
$152B
| $5.49M | 0.94% |
+40,372
| New | +$5.1M |
|
11
Biogen
BIIB
$32.7B
| $5.28M | 0.9% |
17,800
+13,500
| +314% | +$3.75M |
|
12
Edwards Lifesciences
EW
$51.8B
| $5.13M | 0.88% |
66,000
+57,300
| +659% | +$4.47M |
|
13
Walt Disney
DIS
$184B
| $4.99M | 0.85% |
+34,500
| New | +$4.82M |
|
14
Microsoft
MSFT
$3.75T
| $4.45M | 0.76% |
28,200
-18,900
| -40% | -$2.78M |
|
|
SCHW
15
Charles Schwab
SCHW
$187B
| $4.14M | 0.71% |
87,057
+69,396
| +393% | +$3.06M |
|
16
ResMed
RMD
$34B
| $3.97M | 0.68% |
25,598
+5,900
| +30% | +$850K |
|
17
Booking.com
BKNG
$152B
| $3.88M | 0.66% |
47,200
-8,300
| -15% | -$652K |
|
18
Constellation Brands
STZ
$22.4B
| $3.83M | 0.66% |
+20,200
| New | +$3.81M |
|
19
Nutanix
NTNX
$18.9B
| $3.83M | 0.65% |
+122,400
| New | +$3.61M |
|
20
PepsiCo
PEP
$191B
| $3.81M | 0.65% |
+27,872
| New | +$3.79M |
|
21
Ulta Beauty
ULTA
$23.2B
| $3.8M | 0.65% |
+15,000
| New | +$3.67M |
|
|
GRMN
22
Garmin
GRMN
$55.9B
| $3.78M | 0.65% |
+38,700
| New | +$3.61M |
|
23
CVS Health
CVS
$119B
| $3.57M | 0.61% |
48,100
-21,600
| -31% | -$1.52M |
|
24
Dollar General
DG
$27.8B
| $3.57M | 0.61% |
22,879
-18,800
| -45% | -$2.98M |
|
|
DOCU
25
DocuSign
DOCU
$12.2B
| $3.55M | 0.61% |
47,900
+35,367
| +282% | +$2.43M |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.
- Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
- Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
- Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
- Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
- Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
- Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
- Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.
Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.